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ABSTRACT
To evaluate the antiplasmodial and antipyretic activities of 
Z. mays L. (Family- Poacae) cornsilk extract and fractions, to ascertain the 
folkloric claim of its antimalarial and antipyretic activities. The cornsilk 
extract (170–510 mg/kg) and fractions (hexane, dichloromethane, 
ethyl acetate and methanol; 340 mg/kg) were investigated for 
suppressive, prophylactic, and curative antiplasmodial activities 
against chloroquine-sensitive Plasmodium berghei infections in Swiss 
albino mice and for antipyretic activity against D-amphetamine, 
2,4-dinitrophenol and yeast-induced pyrexia. chloroquine (5 mg/kg) 
and pyrimethamine (1.2 mg/kg) were used as positive controls for 
antiplasmodial models and Acetyl salicylic acid, ASA,(100 mg/kg) 
was used as standard for antipyretic models. Thin films made from 
tail blood of each mouse were used to assess the level of parasitaemia 
of the mice. The extract/fractions progressively reduced parasitaemia 
induced by chloroquine-sensitive P. berghei infection in prophylactic 
(46.16–86.80%), suppressive (48.59–71.95%), and curative (22.4–
82.34%) models in mice. These reductions were statistically significant 
(p<0.01–0.001). They also improved significantly (p<0.01–0.001) 
the mean survival time (MST) from 18.91 to 23.66 d in suppressive, 
17.33 to 28.00 in prophylactic and 20.25 to 26.75 d in curative models 
relative to control (13.75 d). The activities of extract/fractions were 
comparable to that of the standard drugs used (pyrimethamine) in 
prophylactic model only. The extract exerted prominent inhibition of 
pyrexia on amphetamine, dinitrophenol and yeast-induced pyrexia 
(5 h). Inhibition was significant (p<0.05–0.001) from 2 to 5 h post- 
administration of extract and in a dose-dependent fashion. The plant 
may possess antiplasmodial and antipyretic effects which may in part 
be mediated through the chemical constituents of the plant.
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INTRODUCTION
Zea mays L.(Poacae) also known as maize or corn, 
is an annual grass plant cultivated through Nigeria 
primarily for human consumption and as animal feed. 
The plant is tall with a fibrous root system and has 
long narrow leaves on opposite side of the stem and 
bears ears that are enclosed in modified leaves known 
as husks.1 Besides its nutritive values, maize grains, 
leaves, cornsilks, stalk, and inflorescence are also 
used in ethnomedicine for the treatment of several 
ailments. The corn silk is used as an antidiabetic or 
diuretic, and decoction of the silk is consumed for the 
treatment of urinary troubles and gallstones.2 Corn 
silk was used in many parts of the world for the treat-
ment of cystitis, gout, kidney stones, malaria, prostate 
hypertrophy, nephritis and heart disorders.3 
Secondary metabolites like flavonoids, saponins, 
alkaloids, tannins, chlorogenic acid, allantoin, and 
phytosterols as well as flavonoids such as maysin, apig-
maysin, 3-methoxymaysine and ax-4-OH-maysin 
have also been identified from corn silk.4 Biological 
activities include; antioxidative stress,5,6 a and kali-
uresis effect,7 hyperglycemic effect,8 nephroprotective 
activity,9 anti- fatigue,10 anti-depressant activity,11 
anti-hyperlipidemic activity,12 anti-diabetic effects.13,14 
Anti-inflammatory activity,15 Antioxidant,16,17,18,19 
anticancer,20 α- amylase inhibitory,21 antidiabetic and 
hypolipidemic activities.22,23 We report in this study 
the antimalarial and antipyretic activities of the corn-
silk extract and fractions of Zea mays.
MATERIALS AND METHODS
Collection and identification of plant 
material
The cornsilk extract of Zea mays L. (Family- 
Poacae) were collected from farms in the Uyo area 
of Akwa Ibom State, Nigeria in May, 2018. The plant 
was identified by a taxonomist in the Department 
of Botany and Ecological Studies, University of 
Uyo, Uyo, Nigeria. A voucher specimen of the 
plant (FPH, 614) was deposited in the Faculty of 
Pharmacy’s herbarium at the University of Uyo.
Extraction
The cornsilk were washed and shade dried for 
two weeks. The dried cornsilk were pulverized 
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to powder using electric grinder. The powdered 
cornsilk were divided into two parts (1.5 kg each). 
One  part was macerated in ethanol for 72  hours, 
while the remaining part was successively and 
gradiently macerated for 72 hours in each of, 
n-hexane, dichloromethane, ethyl acetate and 
n-butanol respectively, which is along their polarity 
to give the corresponding gradient extract for each 
solvent. The liquid filtrate of each extract and frac-
tion was concentrated and evaporated to dryness in 
vacuo 40°C using a rotary evaporator. The extract 
and fraction were stored in a refrigerator at -4°C, 
until used for the proposed experiments.
Microorganism (parasite)
Chloroquine-sensitive strain of Plasmodium berghei 
berghei were obtained from the National Institute 
of Medical Research (NIMER), Yaba Lagos, Nigeria 
and maintained by subpassage in mice. 
Parasite inoculation
Each mice used in the experiment were inoculated 
intraperitoneally with 0.2 mL of infected blood 
containing about 1 x 107 P. berghei berghei parasit-
ized erythrocytes. The inoculum consisted of 5 x 107 
P.berghei berghei erythrocytes per milliliter. This 
was prepared by determining both the percentage 
parasitemia and the erythrocytes count of the donor 
mouse and diluting the blood with isotonic saline 
in proportions indicated by both determinations.24
Experimental animals
Male and female swiss albino rats (125-150 g) and 
mice, (18-25 g), were obtained from the University 
of Uyo’s animal house. They were kept in standard 
cages and acclimatized for a period of 10 days before 
use in the experiments. The mice were fed on stan-
dard pelleted diet and water ad libitum. All animals 
were kept at room temperature in cross ventilated 
rooms. The care and use of animals were conducted 
in accordance with the National Institute of Health 
Guide for the Care and Use of laboratory Animals 
(NIH Publication, 1996). Approval for the study 
was obtained from the University of Uyo’s Animal 
Ethics Committee.
Determination of median lethal dose (LD50)
The median lethal dose (LD50) of the extract was 
estimated using albino mice by intraperitoneal 
(i.p) route using the method of Lorke25 as reported 
by Okokon et  al.26 This involved intraperitoneal 
administration of different doses of the extract 
(100– 1000 mg/kg) to groups of three mice each. The 
animals were observed for manifestation of physical 
signs of toxicity such as writhing, decreased motor 
activity, decreased body/ limb tone, and decreased 
respiration and death. The number of deaths in each 
group within 24 h was recorded. The LD50 value was 
calculated as geometrical means of the maximum 
dose producing 0% (a) and the minimum dose 
producing 100% mortality (b). LD50 =√ ab 
Drug administration
The extract, fractions, chloroquine and pyrimeth-
amine that were used in the study were admin-
istered orally with the aid of a stainless metallic 
feeding cannula.
Evaluation of the in vivo antimalarial 
activities of cornsilk extract and fractions of 
Zea mays:
Evaluation of suppressive activities of the 
cornsilk extract and fractions of Zea mays 
(4-day test)
This test was used to evaluate the schizontocidal 
activity of the crude extract and fractions as well as 
chloroquine against early P. berghei berghei infec-
tion in mice. This was done using the method of 
Knight and Peters27 as described by Okokon et al.28 
Fifty-four mice were randomly divided into nine 
groups of six mice each. On the first day (D0), 
the fifty-four mice were infected with the parasite 
and randomly divided into various groups. These 
were administered the crude extract, fractions, 
chloroquine and distilled water. The mice in 
group 1-3 were given 170 mg/kg, 340 mg/kg and 
510 mg/kg of crude extract respectively, while 
groups 4, 5, 6, 7 were administered 340 mg/kg of 
n-hexane, dichloromethane, ethyl acetate, and 
n-butanol fractions respectively, group 8 was given 
5 mg/kg of chloroquine (positive control) and 
group 9 given 10 mL/kg of distilled water (negative 
control) for four consecutive days (D0-D3) between 
8am to 9am. On the fifth day (D4), thin films were 
made from the tail blood. The films were stained 
with Giemsa stain to reveal parasitized erythrocytes 
out of 500 in a random field of the microscope. 
The average suppression of parasitemia was calcu-
lated as follows: (average % parasitemia positive 
control – average % parasitemia negative control) / 
(average % parasitemia negative control).
The mean survival time of the mice in each 
treatment group was determined over a period of 
29 days (D0-D28), as follows:
(No. of days survived) / (total No. of days (29) × 100
Evaluation of prophylactic or repository 
activities of the cornsilk extract and fractions 
of Zea mays
This was evaluated using the method of Peters29 
as described by Imoh et  al.,30 The mice were 
randomly divided into nine groups of six mice 
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per group. Groups 1-3 were given 170, 340, and 
510  mg/kg of crude extract respectively, groups 
4, 5, 6, and 7 were given 340 mg/kg of n-hexane, 
ethyl acetate, dichloromethane, and n-butanol 
fractions respectively, group 8 was given 1.2 mg/
kg of pyrimethamine (positive control) and group 
9 given 10 mL/kg of distilled water (negative 
control). Administration of the extract and frac-
tions continued for three consecutive days (D0-D2). 
On the fourth day (D3), the mice were inoculated 
with P.  berghei berghei. The parasitemia level was 
assessed by blood smears 72 hours later. The mean 
survival time of the animals were calculated over a 
period of 29 days.
Evaluation of the curative activities of the 
cornsilk extract and fractions of Zea mays
This test was used to evaluate the schizontocidal 
activity of the extract, fractions and chloroquine 
in established plasmodial infection. This was 
conducted according to the method of Ryley and 
Peters31 as described by Okokon et  al.32 P. berghei 
berghei was injected intraperitoneally into another 
fifty four mice on the first day (D0). Seventy two 
hours later (D3), the mice were divided into nine 
groups of six mice per group. Groups 1-3 were given 
different doses of extract, 170, 340, and 510  mg/
kg respectively, groups 4-7 were given 340  mg/kg 
of n-hexane, ethyl acetate, dichloromethane, and 
n-butanol fractions respectively, group 8 was given 
5 mg/kg chloroquine (positive control) and group 
9 was given 10 mL/kg distilled water (negative 
control). The crude extract, fractions and chlo-
roquine were administered once daily for 5 days. 
Giemsa stained thin smears were prepared from tail 
blood samples collected on each day of treatment 
to monitor the parasitemia level. The mean survival 
time (MST) of the mice in each group was deter-
mined over a period of 29 days (D0-D28).
Evaluation of antipyretic activity
Evaluation of antipyretic activity of the 
cornsilk extract on D-amphetamine-induced 
pyrexia
Adult albino rats (130 – 150 g) of both sexes fasted 
for 24 hours but allowed water ad libitum were used 
for the experiment. They were randomized into 
groups of 6 rats each. Amphetamine (5 mg/kg, i.p) 
was administered to the animals after obtaining 
basal temperatures. Hyperthermia developed 0.5 h 
following amphetamine administration. Different 
doses of extract (170, 340 and 510 mg/kg i.p), 
aspirin (100 mg/kg) and distilled water (10 mL/
kg, orally) were administered respectively to the 
treatment and control groups of animals. Rectal 
temperatures of the animals were obtained at an 
hour interval for 5 h.33,34
Effect of cornsilk extract on 
2,4-Dinitrophenol (DNP)-induced pyrexia
Adult albino rats of both sexes fasted for 24 h but 
allowed water ad libitum were used for the exper-
iment. They were randomized into groups of six 
rats each. DNP (10 mg/kg, i.p.) was administered 
to the rats after obtaining the basal rectal tempera-
tures. Hyperthermia developed within 30 min of 
DNP administration. Different doses of extract 
(170, 340, and 510 mg/kg i.p.), aspirin (100 mg/
kg), and distilled water (10 mL/kg, orally) were 
administered to the treatment and control groups 
of animals. Rectal temperatures of the animals were 
obtained at 1 h intervals for 5 h.34
Effect of cornsilk extract on yeast-induced 
pyrexia
Adult albino rats (125 – 130 g) of both sexes fasted 
for 24 hours but allowed water ad libitum were 
used for the experiment. They were randomized 
into groups of 6 rats each. At zero hour, the basal 
temperature of the rats was taken using digital 
clinical thermometer. Thereafter, each animal 
was administered subcutaneously with 20% 
W/V aqueous suspension of yeast at a volume 
of 10 mL/kg.34 At suitable intervals beginning 
one hour after yeast injection, rectal temperature 
of animals were taken, animals with increase of 
1°C were selected and grouped for the study. The 
extract understudy was administered i.p. after 
the pyrogen at doses of 170, 340 and 510 mg/kg 
to respective groups of rats. The control group 
received distilled water (10 mL/kg) and the refer-
ence group administered with ASA (100 mg/kg) 
both orally. The rectal temperature of the groups 
was taken at 1h interval for 5h.
Statistical analysis
Data obtained from this work were analyzed statis-
tically using ANOVA (One- way) followed by a post 
test (Turkey-Kramer multiple comparison test). 
Differences between means were considered signif-
icant at 5% level of significance, that is p ≤ 0.05.
RESULTS
Determination of median lethal dose (LD50) 
The median lethal dose (LD50) value was calculated 
to be 1732.05 mg/kg. The physical signs of toxicity 
included excitation, paw licking, increased respira-
tory rate, decreased motor activity, gasping, convul-
sion and coma which was followed by death.
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Suppressive activities of ethanol cornsilk 
extract and fractions of Z. mays
The extract and its fractions exerted dose-depen-
dent reductions in parasitaemia of the treated 
mice in various groups. These reductions were 
statistically significant relative to the control 
(p<0.001). The methanol fraction demonstrated 
the highest suppressive activity (71.95%) and m.s.t 
value of 22.66 d although less than that of the stan-
dard, Chloroquine, 5 mg/kg (94.02%) (Table 1).
Table 1  Suppressive activities of cornsilk extract and fractions during early Plasmodium 
berghei berghei infection in mice 
Treatment Dose (mg/kg) Parasitaemia Chemosuppression (%) MST
Control - 35.66 ±1.20 - 13.00 ±0.66
extract 170 15.0±5.00a 57.93 18.91±0.35
340 12.0±4.00a 66.34 22.06±1.33
510 10.0±3.05b 71.95 23.66±0.68
n-hexane 340 18.33 ±1.20a 48.59 14.50 ±1.52
Dichloromethane 340 14.00± 1.20b 60.74 17.66 ±1.33a
Ethyl acetate 340 12.66± 3.93b 64.49 21.0 ±2.64a
Methanol 340 10.0 ± 5.00b 71.95 22.66±1.33b
Chloroquine 5 2.13 ± 2.02c 94.02 30.00 ±0.00c
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6
Table 2 Prophylactic activities of cornsilk extract and fractions 
Treatment Dose (mg/kg) Parasitaemia Chemosuppression (%) MST
Control - 17.66 ±1.45 - 13.0 ±0.57
Extract 170 9.33±1.45a 46.16 23.60±3.28a
340 7.60±1.20b 56.96 24.60±2.18a
510 7.0±2.30b 60.36 25.60±0.57
n-hexane 340 4.0 ±1.52c 77.34 28.00 ±1.52b
Dichloromethane 340 3.0± 1.52c 83.01 17.33 ±0.33
Ethyl acetate 340 3.0± 0.57c 83.01 24.60 ±2.90a
Methanol 340 2.33± 1.33c 86.80 26.66 ±1.20b
Pyrimethamine 1.2 2.66 ± 1.33c 84.93 25.04 ±0.29
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6
Table 3  Mean survival time of mice treated with cornsilk extract and fractions during 
established Plasmodium berghei berghei infection 
Treatment Dose (mg/kg)
Mean Survival Time
(Days)
Control - 13.75 ±1.43
Extract 170 20.50±1.55a
340 21.25±1.03a
510 22.50±0.50b
n-hexane 340 24.25 ±1.20a 
Dichloromethane 340 20.25±1.37b
Ethyl acetate 340 26.75± 1.97c
Methanol 340 22.75 ± 0.75b
Chloroquine 5 30.00± 0.00c 
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6.
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Prophylactic/repository activities of 
ethanol cornsilk extract and fractions of Z. 
mays
The ethanol cornsilk extract showed dose-depen-
dent reductions of parasitaemia in the extract-
treated groups. These reductions were statistically 
significant relative to the control (p<0.01– 0.001). 
The methanol fraction showed the most promi-
nent prophylactic activity (86.80%) and m.s.t value 
of 26.66 d which was significant (p<0.001) when 
compared with control but was comparable to that 
exhibited by the standard drug, pyrimethamine, 
1.2 mg/kg (Table 2).
Antiplasmodial effect of ethanol cornsilk 
extract and fractions of Z. mays on 
established infection
There were progressive dose-dependent reductions 
of parasitaemia in all the extract/fraction-treated 
Table 4  Antipyretic effect of cornsilk extract on D-amphetamine-induced pyrexia
Treatment/
Dose(mg/kg)
 TIME INTERVALS (hrs)
Basal Temp 0 0.5 1.0 2.0 3.0 4.0 5.0
Control 35.57±0.46 36.97±0.44 36.20±0.61 36.65±0.72 36.93±0.74 37.15±0.71 37.25±0.70 37.20±0.70
Extract 170 34.67±0.08 35.82±0.52 35.77±0.32 35.87±0.25a 35.22±0.44a 35.12±0.22b 34.52±0.19a 34.77±0.28b
Extract 340 35.30±0.33 36.42±0.28 36.02±0.49 36.25±0.50 35.10±0.33a 34.87±0.30a 33.80±0.30b 33.90±0.36c
Extract 510 34.65±0.24 35.87±0.38 35.60±0.45 35.62±0.10 34.82±0.24a 34.60±0.38b 33.97±0.31b 33.67±0.22c
ASA 100 34.77±0.14 35.72±0.47 34.87±0.18 34.72±0.20 34.75±0.18a 34.17±0.19c 33.95±0.02c 33.65±0.06c
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6.
Table 5 Antipyretic effect of cornsilk extract on Dinitrophenol-induced pyrexia
Treatment/
Dose(mg/kg)
 TIME INTERVALS (hrs)
Basal Temp 0 0.5 1.0 2.0 3.0 4.0 5.0
Control 34.92±0.34 36.55±0.46 36.07±0.49 36.55±0.67 36.27±0.51 35.57±0.23 36.07±0.41 36.17±0.41
Extract 170 34.40±0.14 36.72±0.34 36.90±0.81 36.70±0.58 36.20±0.56 35.37±0.42 33.85±0.25c 33.32±0.45b
Extract 340 34.95±0.13 35.97±0.54 36.00±0.56 35.75±0.45 34.93±0.33 34.00±0.35b 33.76±0.34c 33.23±0.50b
Extract 510 35.00±0.20 36.27±0.22 35.97±0.41 36.72±0.56 35.32±0.49 35.32±0.28 33.82±0.11c 33.07±0.43c
ASA 100 34.52±0.13 36.07±0.37 35.82±0.35 35.50±0.12 34.97±0.18 34.57±0.07 33.30±0.17c 32.80±0.20c
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6.
Table 6 Antipyretic effect of cornsilk extract on yeast-induced pyrexia
Treatment/
Dose(mg/kg)
 TIME INTERVALS (hrs)
Basal Temp 0 0.5 1.0 2.0 3.0 4.0 5.0
Control 35.95±0.29 37.17±0.31 37.87±0.74 37.82±0.10 37.75±0.68 37.70±0.37 37.77±0.29 37.50±0.23
Extract 170 35.60±0.60 37.00±0.37 36.95±0.38 36.95±0.40 36.25±0.42 36.02±0.42a 36.27±0.39a 36.30±0.54
Extract 340 35.75±0.51 37.10±0.55 36.20±0.73 36.37±0.17 36.32±0.39 36.02±0.59a 36.37±0.45a 36.10±0.61a
Extract 510 35.12±0.55 37.22±0.40 36.10±0.14 36.40±0.23 36.60±0.35 36.00±0.47b 36.00±0.45b 35.32±0.34b
ASA 100 35.20±0.31 37.12±0.49 36.67±0.51 36.22±0.21 36.40±0.60 36.17±0.31b 35.35±0.49c 35.30±0.27c
Values are expressed as mean ± SEM. Significance relative to control. ap<0.05; bp<0.01; cp<0.001. n = 6.
Figure 1  Curative activities of Cornsilk extract and fractions during estab-
lished Plasmodium berghei infection in mice.
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groups relative to control. These reductions were 
statistically significant relative to the control 
(p<0.001; Figure 1). The methanol fraction had the 
highest activity with chemosuppressive effect of 
84.93%, this was lower compared with that of the 
standard, chloroquine,100%.
The cornsilk extract and fractions demonstrated 
significant (p<0.05-0.001) protective potentials on 
the mice as was seen in the mean survival time of 
the animals. The groups treated with ethyl acetate 
fraction had a longer mean survival time, 26.75 
± 1.97 d followed by those of methanol fraction 
treated mice, 22.75 ± 0.75 d. These were less than 
that of the standard drug, chloroquine (30.00 ± 0.00 
d; Table 3).
Effect of ethanol cornsilk extract on 
D-amphetamine induced pyrexia
The antipyretic effect of the extract on amphet-
amine- induced pyrexia is shown in Table 4. 
Cornsilk extract (170-510 mg/kg), in the presence 
of the pyrogen, caused significant (p<0.05 – 0.001) 
reductions in the temperatures of the extract- 
treated rats when compared with the control. These 
effects were pronounced at the 4 h and 5 h post 
treatment with the extract. The antipyretic effects of 
the extract were comparable with that of the stan-
dard drug, ASA,100 mg/kg (Table 4).
Effect of ethanol cornsilk extract on 
2,4-dinitronitrophenol (DNP)-induced 
pyrexia in rats
The cornsilk extract (170-510 mg/kg) demonstrated 
significant (p<0.05–0.001) dose-dependent lower-
ing of temperature in DNP-induced pyretic rats. 
The antipyretic effect was, however, pronounced 
(p<0.05–0.001) at the 5 h in all the extract-treated 
groups. The effect of the highest dose (510 mg/kg) 
was comparable to that of the standard drug, ASA, 
100 mg/kg (Table 5).
Effect of cornsilk extract of on yeast-
induced pyrexia in rats
Ethanol cornsilk extract of Z. mays (170-510 mg/
kg) caused significant (p>0.05-0.001) reduction 
of rat body temperature of rats elevated by the 
administration of yeast. The effect of the extract was 
pronounced at the 5 h. The antipyretic effects of the 
extract was not comparable to that of the standard, 
ASA,100 mg/kg (Table 6).
DISCUSSION
The cornsilk tea is used traditionally by the Ibibios 
of Southern Nigeria and other parts of the world as 
a malarial remedy and febrifuge.35 This work was 
designed to evaluate the antimalarial and antipyretic 
activities of the cornsilk extract and fractions of 
Zea mays. The median lethal dose (LD50) value was 
calculated to be 1732.05 mg/kg which shows that the 
cornsilk extract is slightly toxic.36 The antimalarial 
activity of the cornsilk extract and fractions was eval-
uated against rodent malaria parasite, Plasmodium 
berghei berghei infection in mice using standard in 
vivo models. The extract and fractions were found 
to significantly reduced parasitemia in suppressive, 
prophylactic and curative models in a dose-depen-
dent fashion with the methanol fraction exerting 
the highest antimalarial activity. The extract and 
fractions also prolonged the MST of the mice consid-
erably suggesting that they were potentially able to 
offer significant degree of protection to the mice. This 
activity could have resulted from plasmodicidal or 
plasmodistatic activity of the extract and fractions. 
The observation that the extract and fractions 
showed considerable in vivo activity suggest also the 
involvement of antioxidant activity which maybe 
due to the activities of phytochemical compounds 
present in the cornsilk extract and fractions. 
Besides, the cornsilk fractions have been 
observed in this study to exhibit pronounced 
antioxidant activity16,17,18 and the cornsilk extract 
has been known to be rich in flavonoids15 which 
are known for significant antioxidant activity. 
Antioxidant potentials of some plant and natural 
products especially flavonoids have been found 
to promote schizonticidal activity by modulating 
the cellular signalling pathway37 and this has been 
suggested to be responsible for antiplasmodial activ-
ity of compounds such as quercetin38 as elevated 
free radicals levels which are common features of 
malaria disease are implicated in severe malaria 
complications. This also could be one of the modes 
of action of this extract as it contains phenolics 
and flavonoids with antioxidant activity. Moreso, 
flavones glycosides with antioxidative activity have 
been reported in cornsilk extract,39 which further 
confirms the antioxidative potentials. These may in 
part contribute to the strong antimalarial and anti-
oxidant activities of the cornsilk extract.
Other mechanisms of antiplasmodial activity 
have been proposed for flavonoids besides antiox-
idant activity. Flavonoids are known to exert anti-
plasmodial activity by chelating with nucleic acid 
base pairing of the parasite,40 thereby producing 
plasmocidal effect. Other modes of action include 
modulation of host immunity to tackle disease 
and inhibition of plasmodial enoyl-ACP reductase 
(FAB I enzyme)—a key regulator of type II fatty 
synthases (FAS-II) in P. falciparum.41,42 Flavonoids 
may also bind the parasite’s serinethreonine kinase 
with high affinity and affect its development.43 
These compounds (flavonoids) present in this plant 
extract and in particular the methanol fraction may 
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in part have contributed to the plasmocidal activity 
of this extract/fraction and therefore explained the 
mechanism of antiplasmodial effect of the extract.
On antipyretic activity, the extract inhibited 
significantly amphetamine, dinitrophenol and 
yeast-induced pyrexia. The cornsilk extract (170-
510 mg/kg) showed considerable dose-dependent 
reduction in the elevated temperatures of the 
extract-treated rats in the three models (amphet-
amine, DNP and yeast-induced pyrexia) evaluated. 
The antipyretic effect was sustained throughout the 
duration of the work with the effect being quite 
comparable to ASA (100 mg/kg). Pyrexia (fever) 
is the body’s response to tissue damage, inflamma-
tion, malignancy or graft rejection that results in 
the formation of large amounts of cytokines, inter-
leukin, interferon and TNF-α, and increasing PGE2 
to trigger the hypothalamus and then cause fever.
In the brain, amphetamine causes the release of 
biogenic amines that are stored in nerve terminals 
leading to increases in the cAMP level, resulting in 
prostaglandins synthesis from arachidonic acids in 
neurons through hydrolysis of phospholipids. This 
results in hyperthermia.44 DNP causes hyperthermia 
by uncoupling oxidative phosphorylation resulting 
in calcium release from mitochondrial stores and 
preventing calcium reuptake. This leads to increased 
intracellular calcium level, muscle contraction and 
hyperthermia.45 The extract through its components 
may have caused stimulation of the sarcoplasmic 
reticulum Ca2+-ATPase thus promoting calcium 
reuptake into the sarcoplasmic reticulum, muscle 
contraction and hypothermia.46 Yeast induced 
pyrexia which is pathogenic and caused by PGE2 
production, which then resets the thermoregulatory 
center in the hypothalamus to a higher level.47
Antipyretics lower elevated body temperature by 
suppressing cyclooxygenase actions and decreasing 
PGE2 levels in the hypothalamus.48 Temperature 
regulation involves a delicate balance between heat 
production and loss, and the hypothalamic thermo-
stat.48 Cyclooxygenase (COX2) activity leads to the 
synthesis of PGE2 which is an imperative mediator 
of fever within the hypothalamus and most NSAIDs 
antipyretic activity results from suppression of 
prostaglandin synthetase in the hypothalamus. The 
resultant antipyretic effects could be due to reduced 
PGE2 levels in the hypothalamus acting on COX2, 
or through increased production of substances such 
as vasopressin and arginine that reduce tempera-
ture.49 Another possible antipyretic mechanism of 
the extract is the mediation of the vasodilation of 
superficial blood vessels which causes improved 
heat loss from resetting of hypothalamic thermo-
stat.49 The extract may have caused hypothermia by 
acting through any of these mechanisms.
Flavonoids such as baicalin exhibit antipyretic 
activity by inhibiting tumour necrosis factor,47 and 
related compounds also suppress arachidonic acid 
peroxidation, resulting in decreased prostaglandin 
levels and fever reduction.50 The phytochemical 
constituents of this extract which include flavo-
noids and other phenolic compounds4 may be 
responsible for its antipyretic effect through any or 
all mechanisms described here.
The results of this study demonstrated that corn-
silk extract of Zea mays possibly possesses consid-
erable antiplasmodial and antipyretic properties. 
These confirm its use to treat malaria and fever in 
folkloric medicine. Therefore, it would be interest-
ing if the active principle is isolated, identified, and 
characterized.
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